Together with Mitsubishi Chemical Safety Institute Ltd., which is famous for its outstanding analytical ability in the medical and pharmaceutical fields, Mitsubishi Chemical Medience Corporation is providing seamless services for preclinical studies to clinical studies under the regulations of GCP. In order to answer increasing needs for outsourcing parts of drug development processes of pharmaceutical companies, total services offered by the group include SMO business and various contact testing and analyses: determination of drug concentrations, or measurement of safety or efficacy markers for pharmacokinetic studies or safety studies under the regulations of GLP.
Molecuence Corporation contributes to realization of personalized medicine by seeking various biomarkers with state of art technologies accumulated in the group such as various Omics technologies.